Latest CSL News | Page 4

International shares now rivalling Australian blue chips
Allens advises CSL on A$16.4 billion Vifor Acquisition and A$6.3 billion capital raising
HSF has advised Joint Lead Managers of CSL Limited’s A$6.3b placement – largest transaction of its kind by an Australian company
Minister updated on research into Omicron variant, AIID Foundation Partners Agreement signed
Infectious Disease Institute Partners Set New Foundation
CSL completes $6.3 billion placement to support Vifor acquisition
Step forward for AIID
CSL Announces Tender Offer To Acquire Vifor Pharma
CSL Committed to mRNA Program
Australia Post appoints first ever customer experience and digital executive
2 out of 3 members of university governing bodies have no professional expertise
CSL Joins StartX Community
Vaccine Operations Centre – Weekly Operational Update 25 November
CSL’s new headquarters will be home to biotech incubator
New biotech incubator in Melbourne to drive world-class medical research
Breakthrough Funding To Boost Biotech Start-Ups
Melbourne Biotech Incubator
Vaccine Operations Centre – Weekly Operational Update 17 November
Vaccine Operations Centre – Weekly Operational Update 10 November
Mr Geoffrey Kempler announced as new AusBiotech Chair
Vaccine Operations Centre – Weekly Operational Update 4 November
Vaccine Operations Centre – Weekly Operational Update 2 November
Faster treatments for pandemics/molecular factories
Cancer researcher wins $1.25M CSL Centenary Fellowship
$2.5 million CSL Centenary Fellowships awarded
Vaccine Operation Centre – Weekly Operational Update
Robot with eyes, gum disease vaccine and circadian clock lighting technology take out CRA Excellence
CSL Research and Development Day 2021
Research-industry partnership to advance biologic therapies
Australian production of AstraZeneca’s Covid vaccine, Vaxzevria, to continue into 2022
CSL Committed to AZ COVID Vaccine
Vaccine Operations Centre – Weekly Operational Update 13 October
CSL Requires Covid Vaccination
Vaccine Operations Centre – Weekly Operational Update 7 October
Melbourne-made Covid treatment could future-proof Australia
Preparing Australians for COVID-19 vaccination roll-out
Appointments to Reserve Bank of Australia Board
Australia secures 20 million extra Astra Zeneca vaccines for onshore manufacturing
Australia secures 20 million extra Astra Zeneca vaccines
AFAO statement on UQ vaccine candidate
Update on University of Queensland COVID-19 vaccine
Update on UQ COVID-19 vaccine
Australian researcher recognised for work in developing next generation treatments for Parkinson’s disease
Survey of ASX leaders shows how businesses can rise in 2021
COVID-19 vaccine alternative protein and unlocking Northern Australia celebrated at CSIRO awards
National recognition for WEHI bioinformatics researchers
Expert commentary: Oxford and AstraZeneca vaccine preliminary Phase III data
Nanobodies could hold clues to new COVID-19 therapies